Parallax Volatility Advisers’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Parallax Volatility Advisers's NVS Position: Q2 2026 in Review
Parallax Volatility Advisers opened a new position in Novartis (NVS) in Q2 2026: 1,602 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #1210 among its holdings. This is a return to the name: Parallax Volatility Advisers previously reported a position in NVS as recently as Q4 2024.
Parallax Volatility Advisers first reported a position in NVS in Q3 2018 and has held it in 13 quarters since. The position peaked at $18M in Q1 2019. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Parallax Volatility Advisers held 1,602 shares of Novartis worth $251K as of Q2 2026.
- Novartis was a new Parallax Volatility Advisers position in Q2 2026.
- Novartis made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q2 2026, its #1210 holding.
- Parallax Volatility Advisers first reported a position in Novartis in Q3 2018 and has held it in 13 quarters since.
- Parallax Volatility Advisers's Novartis position peaked at $18M in Q1 2019.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Parallax Volatility Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.